In addition, IGU protects against inflammatory arthritis by activating the nuclear factor-κB (NF-κB) signaling pathway and downregulating sodium bicarbonate cotransporter e2 (NBCe2) in RA patients to inhibit protein citrullination and inflammation. The gene discussed is SLC4A5; the disease is rheumatoid arthritis.